| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2012 | CN101808642B Mast cell stabilizers in the treatment of obesity |
| 05/02/2012 | CN101808636B Treatment of melanoma |
| 05/02/2012 | CN101804068B Polyethylene glycol-electrolyte oral solution |
| 05/02/2012 | CN101797247B Application of isoflavone compound in preparation of anti-tumor drug or food |
| 05/02/2012 | CN101787004B Lignanoid compound contained in Yunnan daphne herb, as well as preparation method and application thereof |
| 05/02/2012 | CN101785832B Traditional Chinese medicine preparation and preparation method thereof for skin disease treatment |
| 05/02/2012 | CN101780126B Ginsenoside compound in syringa pubescens turca and extraction method and application thereof |
| 05/02/2012 | CN101768126B Novel triazole antifungal compound and salt thereof |
| 05/02/2012 | CN101766709B Pharmaceutical composite for osteoporosis treatment and preparation method thereof |
| 05/02/2012 | CN101732703B Composition for antagonizing pyretic effect of endotoxin in vaccine on livestock and application thereof |
| 05/02/2012 | CN101732395B Medicine or health-care food composition with function of regulating immunity, preparation method and application thereof |
| 05/02/2012 | CN101723940B Bithiophene compound and pharmaceutical composite and application thereof |
| 05/02/2012 | CN101700243B Novel medicine carrying woundplast with treating function |
| 05/02/2012 | CN101696202B Phenylpropanoid compound contained in rhodiola, preparation method thereof and application thereof |
| 05/02/2012 | CN101695488B Compound articaine freeze-drying preparation for injection and preparation method thereof |
| 05/02/2012 | CN101693060B Uron medicinal liquor for activating blood, eliminating dampness and removing spur and preparation method thereof |
| 05/02/2012 | CN101671346B Lindenrane-type dimerization sesquiterpenoids, preparation method and applications thereof in pharmacy |
| 05/02/2012 | CN101636156B Pharmaceutical alkyl gallate composition. |
| 05/02/2012 | CN101628045B Medicine for treating hemorrhoids and preparation method thereof |
| 05/02/2012 | CN101597229B Acetoxy-benzo-ketones compound, preparation method and application thereof |
| 05/02/2012 | CN101574444B Rehabilitation medication combination for curing addiction to morphine drugs and preparation method thereof |
| 05/02/2012 | CN101574443B Rehabilitation medication combination for curing addiction to morphine drugs and preparation method thereof |
| 05/02/2012 | CN101564499B Acne dispelling Chinese medicament tincture special for men |
| 05/02/2012 | CN101555241B Ampelopsin pro-dug and preparing method and application thereof |
| 05/02/2012 | CN101537020B Synbiotics of bacillus licheniformis and oligosaccharide class prebiotics and composition and formulation thereof |
| 05/02/2012 | CN101502536B Cedar total flavone as well as preparation method and medical use |
| 05/02/2012 | CN101495482B Aziridinyl-epothilone compounds |
| 05/02/2012 | CN101485675B Adapalene and hydrochloric clindamycin compound gel preparation and preparation method thereof |
| 05/02/2012 | CN101479267B Purine derivatives as A2A agonists |
| 05/02/2012 | CN101468958B Novel ethylene diamine derivative |
| 05/02/2012 | CN101375990B Composition for treating cardiovascular disease and preparation thereof |
| 05/02/2012 | CN101370791B Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 05/02/2012 | CN101367795B Imidazole-5-carboxylic acid derivant and method of preparing the same |
| 05/02/2012 | CN101353378B Zone 2 protein of programmed cell death protein 2 analogue and uses thereof |
| 05/02/2012 | CN101347433B Pharmacy use of 4-aniline quinazoline derivatives |
| 05/02/2012 | CN101343265B Extraction method of effective ingredients of cave flower |
| 05/02/2012 | CN101316593B Formulations of quinolinones |
| 05/02/2012 | CN101284860B Antineoplastic pharmaceutical compositions, preparation method and applications thereof |
| 05/02/2012 | CN101238137B Derivatives of 4-or 5-aminosalicylic acid |
| 05/02/2012 | CN101198331B Solubilization preparation |
| 05/02/2012 | CN101184758B Novel compounds |
| 05/02/2012 | CN101072766B 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
| 05/02/2012 | CN101065363B Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 05/02/2012 | CN101056868B Substituted chroman derivatives, medicaments and use in therapy |
| 05/01/2012 | USRE43343 Inhibitors of histone deacetylase |
| 05/01/2012 | US8168827 Amide derivative |
| 05/01/2012 | US8168820 Deuterated catecholamine derivatives and medicaments comprising said compounds |
| 05/01/2012 | US8168810 7-phenyl-substituted tetracycline compounds |
| 05/01/2012 | US8168804 Large stoke shift NIR dyes |
| 05/01/2012 | US8168803 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 05/01/2012 | US8168797 Oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient |
| 05/01/2012 | US8168795 Selective sphingosine-1-phosphate receptor antagonists |
| 05/01/2012 | US8168794 Pim kinase inhibitors and methods of their use |
| 05/01/2012 | US8168793 Nitrocatechol derivatives as COMT inhibitors |
| 05/01/2012 | US8168788 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
| 05/01/2012 | US8168786 Radiolabeled compounds and uses thereof |
| 05/01/2012 | US8168776 Method for making a 21 nucleotide double stranded RNA chemically linked at one end |
| 05/01/2012 | US8168692 Bone substitute compositions and method of use |
| 05/01/2012 | US8168682 Personal product bar compositions comprising crystalline wax structured premix or delivery vehicle |
| 05/01/2012 | US8168680 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 05/01/2012 | US8168679 Salts of Tramadol and Naproxen and their crystal forms in the treatment of pain |
| 05/01/2012 | US8168677 Method for treatment of inflammatory bowel disease |
| 05/01/2012 | US8168674 Method for treating bronchial diseases |
| 05/01/2012 | US8168673 Compounds having CRTH2 antagonist activity |
| 05/01/2012 | US8168672 Thioamide derivatives as progesterone receptor modulators |
| 05/01/2012 | US8168671 Synthesis of thieno[3,4-b]thiophene, thieno[3,4-b]furan, related compounds and their derivatives and use thereof |
| 05/01/2012 | US8168670 Pyrazolone derivative emulsion formulations |
| 05/01/2012 | US8168669 Therapeutic agent for inflammatory bowel disease and TNF-α production inhibitor |
| 05/01/2012 | US8168668 Compounds |
| 05/01/2012 | US8168667 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
| 05/01/2012 | US8168666 Substituted carbinol compound |
| 05/01/2012 | US8168665 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 05/01/2012 | US8168664 Metaxalone products, method of manufacture, and method of use |
| 05/01/2012 | US8168663 Pharmaceutically acceptable salt of 6-carboxy-2-(3,5 dichlorophenyl)-benzoxazole, and a pharmaceutical composition comprising the salt thereof |
| 05/01/2012 | US8168662 Use of picoplatin to treat colorectal cancer |
| 05/01/2012 | US8168661 Use of picoplatin to treat colorectal cancer |
| 05/01/2012 | US8168659 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators |
| 05/01/2012 | US8168658 Inhibitors of histone deacetylase |
| 05/01/2012 | US8168657 administering a solenopsin derivative such as 2-methyl-6-(2-phenylethyl)piperidine or other piperidine derivatives to treat a tumor or cancer in a patient |
| 05/01/2012 | US8168656 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| 05/01/2012 | US8168655 Compositions and methods for treatment of eye disorders |
| 05/01/2012 | US8168654 Quinuclidine derivatives binding to mucarinic M3 receptors |
| 05/01/2012 | US8168653 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/01/2012 | US8168652 Inhibitors of AKT activity |
| 05/01/2012 | US8168651 Protein kinase modulators |
| 05/01/2012 | US8168650 Therapeutic uses of bicyclic ligands of sigma 2 receptor |
| 05/01/2012 | US8168649 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 05/01/2012 | US8168648 Camptothecin derivatives and uses thereof |
| 05/01/2012 | US8168647 Vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives |
| 05/01/2012 | US8168646 3,4-dihydroquinazoline derivatives |
| 05/01/2012 | US8168645 Arylsulfonamide compounds |
| 05/01/2012 | US8168644 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 05/01/2012 | US8168643 Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
| 05/01/2012 | US8168642 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases |
| 05/01/2012 | US8168641 Aspartyl protease inhibitors |
| 05/01/2012 | US8168640 Cosmetic use of 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carbomamides and related compounds |
| 05/01/2012 | US8168639 Heterotricyclic compounds as serotonergic and/or dopaminergic agents and uses thereof |
| 05/01/2012 | US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 05/01/2012 | US8168636 Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 05/01/2012 | US8168635 Modulators of central nervous system neurotransmitters |